-
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
-
Aurinia Pharmaceuticals to Present at 2020 RBC Capital Markets’ Virtual Global Healthcare Conference
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $20 at RBC Capital Following 'Robust' Phase 3 Data
-
Aurinia Announces Updates to the Board of Directors
-
Aurinia Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference
-
Aurinia Pharmaceuticals (AUPH) PT Raised to $11 at RBC Capital
-
RBC Capital Starts Aurinia Pharmaceuticals (AUPH) at Outperform

